KAHR Medical
Fusion Protein for the Treatment of Cancer and Autoimmune Diseases
KAHR Medical has raised €30M across 3 funding rounds from 4 investors, most recently a Series D+ round in Feb 2020. Based in Jerusalem, Israel; founded 2005; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€30M
€29,757,757
Funding rounds
3
Investors
4
distinct backers
Active since
2013-09
latest 2020-02
Funding by year
EUR raised per yearKAHR Medical — funding by year — interactive chart.
Data table
| KAHR Medical — funding by year | |
|---|---|
| 2013 | €1.8M |
| 2015 | €11M |
| 2020 | €17M |
Signals
High confidenceRaise-next likelihood12
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (21y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-02-25 | Series D+ | €17M | Flerie Invest | View deal → |
| 2015-12-01 | Growth/Late | €11M | DSC Investment,Korea Investment Partners,Mirae Asset Venture Investment | View deal → |
| 2013-09-01 | Seed | €1.8M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData